NCT06767579
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +13 more
- Locations
-
- Department of Anesthesiology and Pain Medicine Yonsei University College of Medicine Seoul, South Korea
Clinical trial condition
Carcinoma
Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.
8,800 public trials
2,090 recruiting studies
Carcinoma trial results
Recruiting
Irinotecan Liposome Combined with S-1 in PD-1/L1 Inhibitor Refractory Recurrent or Metastatic NPC
NCT06657690
- Conditions
- Carcinoma, Disease Attributes, Head and Neck Neoplasms, +16 more
- Locations
-
- Fifth affiliated hosptial of Sun-yat Sen university Zhuhai, Guangzhou, China
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Department ofNuclear Medicine,Xijing Hospital, Fourth Military Medical University, Xi'an, China Xi'an, China, Shaanxi, China
Recruiting
A Value-Driven Study on Reducing Immune Checkpoint Inhibitor Dosing Frequency in Advanced Cancers
NCT06422403
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +28 more
- Locations
-
- Department of Hematology-Oncology, National University Hospita Singapore
NCT06664021
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
- Locations
-
- No.2 People's Hospital of Fuyang city Fuyang, Anhui, China
- Anhui province hospital Hefei, Anhui, China
NCT06766643
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Department of Hepatobiliary Oncology and Radiation Oncology,Tianjin Medical University Cancer Institute & Hospital,Key Laboratory of Cancer Prevention and Therapy,National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer Tianjin, China
Recruiting
Tislelizumab or Tislelizumab Combined With Lenvatinib Neo-adjuvant Treatment for Resectable RHCC
NCT04615143
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- The First Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China
NCT06763289
- Conditions
- Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +12 more
- Locations
-
- The First Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China
NCT06762782
- Conditions
- Adenocarcinoma, Adjuvant Therapy in Patients With Hepatocellular Carcinoma (HCC) at High Risk of Recurrence After Curative Resection or Ablation, Carcinoma, +10 more
- Locations
-
- The First Affiliated Hospital of Nanjing Medical University Nanjing, Jiangsu, China
NCT04803994
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- LKH - Univ. Klinikum Graz Graz, Austria
- Medzinische Universität Innsbruck Innsbruck, Austria
- Klinikum Klagenfurt am Wörthersee Klagenfurt, Austria
- Ordensklinikum Linz Linz, Austria